Delivery Order SPE2DB24D6041-SPE2DB25FKCGX
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,063.86, is for the delivery of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of July 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 1.2 gram Mesalamine, a medication used to treat conditions such as ulcerative colitis. The award has a ceiling value of $1,184.05 and is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 28, 2025. The contract is not designated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,278.66, is for the delivery of 180 tablets of Mesalamine 800 mg delayed-release tablets, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,501.07, is for the delivery of 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has a period of performance through June 12, 2024 and is a Firm Fixed Price Delivery Order. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,061.39 contract is for the delivery of 120-count tablets of the drug mesalamine 1.2 grams, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of October 2, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $6,676.87, is for the supply of 180 tablets of 800 mg Delayed-Release Mesalamine, a medication used to treat inflammatory bowel diseases. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,517.71 firm fixed-price delivery order is for 180 tablets of 800 mg delayed-release mesalamine, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. This award appears to be part of a larger Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of Mesalamine delayed-release 1.2 gram tablets. The contract has a ceiling value of $4,625.78 and a period of performance through April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award. The contract is not set-aside for any socioeconomic...
- This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Mesalamine 800 mg delayed-release tablets, with a ceiling value of $11,775.90 and a performance period through January 2, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,911.42 and an ultimate completion date of June 26, 2025. The contract is for the delivery of 120 tablets of the medication Mesalamine DR 1.2 GM. This is an open competition contract, as it does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
- SPE2DB24D6041Indefinite Delivery Contract
- SPE2DB24D6041-SPE2DB25FKCGXDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mesalamine delayed-release tablets, a medication used to treat ulcerative colitis. The contract has a ceiling value of $2,076.04 and a performance period ending on July 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors mentioned. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that the company holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/10/25 |